RMRishi Mandavia

Rishi Mandavia

*This is an algorithmically generated author record based on publicly available information.

Rishi Mandavia has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Energy-based Options for Male Facial Rejuvenation

    by Rishi Mandavia, Elizabeth Sahonta, Sepideh Shahidi, Tatiana Mandavia

    In recent years, the advancements of minimally invasive, energy-based facial treatments have been followed by an increase in male patient's demand. This article presents a review of current energy-based devices for male facial rejuvenation, aiming to inform clinicians on evidence-based treatment options. A search of the scientific literature in the PubMed database from inception to June 2025 was conducted. Articles were included if they discussed energy-based options for male facial rejuvenation. Out of 70 articles screened, 23 met the inclusion criteria. In included articles, 18 energy-based options used for male facial rejuvenation were reported. This review provides an overview of the wide array of energy-based devices available for male facial rejuvenation. The literature suggests that these technologies can be effectively and safely used to tighten skin, improve contouring while reducing adiposity, enhance skin quality and tone, and manage cosmetic vascular lesions.

  • Top Cited Papers
    Open Access

    Adult-onset hearing loss and incident cognitive impairment and dementia – A systematic review and meta-analysis of cohort studies

    by Ruan-Ching Yu, Danielle Proctor, Janvi Soni, Liam Pikett, Gill Livingston, Glyn Lewis, Anne Schilder, Doris Bamiou, Rishi Mandavia, Rumana Omar, et al.


  • Open Access

    Treatment of periorbital veins with vascular laser: A systematic review and retrospective case series

    by Rishi Mandavia, Muhammad Ahmed, Dilen Parmar, Massimiliano Cariati, Sepideh Shahidi, Tatiana Lapa

    Introduction: Vascular lasers may represent a promising treatment option for periorbital veins. This article aims to: (1) systematically review the literature on the safety and effectiveness of vascular laser treatment for periorbital veins and (2) assess safety and effectiveness through a retrospective case series.Methods: Systematic review: Articles that assessed the safety and effectiveness of vascular laser treatment for periorbital veins were included and quality assessed using the Downs and Black checklist.Case series: Patient records were retrospectively reviewed from January 2020 to November 2023 to identify all patients who underwent laser treatment for periorbital veins.Outcomes assessment included percentage improvement, patient overall satisfaction and adverse effects.Results: Systematic review: Three articles were included, discussing treatment of blue, periorbital veins using a 1064 nm Nd:YAG laser. Patient Fitzpatrick skin Types I–IV were treated with high patient satisfaction rates and complete clearance of treated veins. Adverse effects included pain, erythema, mild oedema, urticaria and blister formation. Quality of included studies ranged from 7 to 14 out of 21 points.Case series: Thirty‐four patients with skin Types I–V were included. Blue and red periorbital veins were treated using 1064 and 532 nm wavelengths respectively. Mean percentage improvement was 4.8 (complete resolution) and patients' overall satisfaction was ranked 3 (completely satisfied). Adverse effects included erythema, oedema, and bruising.Conclusion: Treatment of red and blue periorbital veins using 532 and 1064 nm vascular lasers appears a safe treatment option. The procedure has a short recovery time, with patients able to resume normal activities within 1 day of treatment.


  • An Evidence-based Pathway for Body Dysmorphic Disorder in Facial Aesthetics

    by Rishi Mandavia, Hanna D'SOuza, Thiara Rupasinghe, Massimiliano Cariati, Tatiana Mandavia

    Aesthetic procedures should be avoided in patients with body dysmorphic disorder (BDD) since they can negatively impact mental health and lead to further aesthetic dissatisfaction. There are no evidence-based patient pathways for BDD in facial aesthetics which can result in the failure to identify patients with BDD, leading to unsuitable treatments and suboptimal patient care. We aim to construct the first evidence-based patient pathway for BDD in surgical and nonsurgical facial aesthetics. A systematic review was performed and articles that discussed screening or patient pathways for BDD in field of facial aesthetics were included. We extracted relevant information from each article on screening tools and pathways for BDD. Data were synthesized by summarizing the data under column headings into a structured narrative and into new tables. Based on this synthesis, a practical pathway for BDD was constructed. Forty articles fulfilled the criteria for inclusion. Twenty-eight BDD screening tools were discussed in the included articles, and we provide an overview of these tools. Thirty-one articles discussed patient pathways for BDD, and we synthesized this information into a structured narrative. Combining these findings, we present an evidence-based patient pathway for BDD for patients presenting for facial aesthetic treatments. This systematic review has resulted in the first, evidence-based, patient pathway for BDD in surgical and nonsurgical facial aesthetics. This practical pathway can be used by aesthetic clinicians to identify patients with potential BDD and provide clear guidance for managing cases where BDD is suspected. It will help reduce the number of facial aesthetic procedures performed on patients with BDD, safeguard patient mental well-being, and prevent further aesthetic dissatisfaction.


  • Open Access

    Cataloging Existing Hearing Loss Cohort Data to Guide the Development of Precision Medicine for Sensorineural Hearing Loss: A Systematic Review of Hearing Repositories

    by Priya Sethukumar, Rishi Mandavia, Omursen Yildirim, Georgina Hazell, Haran Devakumar, Muhammad Ahmed, Emilien Stragier, Marie Josée Duran, Anne G.M. Schilder, Nishchay Mehta

    Recent breakthroughs in our understanding of sensorineural hearing loss etiology have encouraged the identification of novel hearing therapeutics, paving the way for precision hearing medicine. Critical to this field is the curation of health resources on hearing data. A systematic review of the literature was conducted to map existing (inter)national and regional datasets that include hearing data to inform the development of future hearing repositories. Systematic literature review was performed adhering to Preferred Reporting Items for Systematic Review and MetaAnalysis recommendations. Databases, including those from gray literature, were searched to identify publications reporting on phenotypic and/ or genotypic hearing data in May 2019. The databases reviewed were Medline, PubMed, Embase databases, and Google Scholar. Publications on local datasets were excluded. All hearing datasets identified in the screening process were noted. For each dataset, geography, context, objective, period of time run, numbers and demographics of participants, genomic data, hearing measures and instruments used were extracted and cataloged. One hundred and eighty-eight datasets were identified, containing hearing data on populations ranging from 100 to 1.39 million individuals, and all extracted data have been cataloged. This searchable resource has been made accessible online. This unique catalog provides an overview of existing datasets that contain valuable information on hearing. This can be used to inform the development of national and international patient data repositories for hearing loss and guide strategic collaboration between key stakeholder groups, pivotal to the delivery and development of sensorineural hearing loss precision diagnostics and treatments. Cite this article as: Sethukumar P, Mandavia R, Yildirim O, et al. Cataloging existing hearing loss cohort data to guide the development of precision medicine for sensorineural hearing loss: A systematic review of hearing repositories. J Int Adv Otol. 2023;19(5):420-425.


  • An Overview of Rhinoplasty Practices: European Academy of Facial Plastic Surgery, Collaborative Cross-Sectional Study

    by Rishi Mandavia, Dilen Parmar, Muhammad Nayeem Ahmed, Veysel Berber, Diego Sanz, Bruno Paulucci, Alwyn Ray D'Souza, on behalf of the EAFPS Rhinoplasty Research Network

    This collaborative European Academy of Plastic Surgery (EAFPS) study aimed to provide an overview of rhinoplasty practices, informing clinician and patient decision making. It is a multicenter cross-sectional study, reported as per Strengthening the Reporting of Observational Studies in Epidemiology guidelines. All EAFPS members were contacted via email, inviting them to participate. Members expressing an interest to participate were asked to anonymously complete a questionnaire, related to rhinoplasties that they performed as first/supervising surgeon over a period from January 1, 2019 to January 1, 2022. A descriptive analysis was performed. One hundred and fifteen surgeons submitted data on 41,259 rhinoplasties from 33 countries. Eighty percent of rhinoplasties were primary, and 20% were secondary. Thirty five percent of primary rhinoplasties were closed and 65% were open. Thirty one percent of primary rhinoplasties were for cosmetic indications, 11% functional and 58% were for both. Of the 8147 secondary rhinoplasties, 44% were closed and 56% were open. Thirty percent were for cosmetic indications, 11% functional, and 59% for both cosmetic and functional. Ninety-one percent of rhinoplasties were performed by ENT surgeons, 3% by plastic surgeons, 5% by maxillofacial surgeons, and 1% were dual (maxillofacial and ENT) trained. One-thousand seven-hundred thirty primary rhinoplasties underwent revision surgery (5%) and 102 secondary rhinoplasties underwent revision surgery (1%). The most commonly reported indications for revision surgery were dorsal asymmetry, nasal blockage, and dissatisfaction with nasal tip. Three percent of rhinoplasties underwent preoperative psychological assessment. To the authors knowledge, this is the largest published rhinoplasty dataset. This study provides an overview of rhinoplasty practices that can be used for benchmarking and to guide clinician and patient decision making. Psychological assessment of prerhinoplasty appears insufficient with higher levels recommended to minimize unsuccessful outcomes. This study showcases the power of collaborative research and may serve as a catalyst for future collaborative facial plastic surgery research.


  • Combination radiofrequency microneedling and carbon dioxide laser for acne scarring: A systematic review and retrospective case series across two centers

    by Rishi Mandavia, Massimiliano Cariati, Sepideh Shahidi, Cheka Spencer, Michael Somenek, Tatiana Lapa

    Introduction: Combination radiofrequency (RF) microneedling with fractional ablative carbon dioxide (CO2) laser is a new approach for acne scar treatment. Aims: (1) to systematically review the literature on the safety and effectiveness of this treatment for acne scarring; (2) to assess safety and effectiveness in a 2‐center case series.Methods: Systematic review: Articles that assessed the safety and effectiveness of combination RF microneedling and fractional CO2 laser for acne scarring were included and quality assessed using the Downs and Black checklist. Case series: Patient records were reviewed from 2 clinics, one in London, UK, and the other in Washington D.C., United States, to identify patients who underwent a single treatment with RF microneedling and fractional CO2 laser for acne scarring. Outcome assessment was via the Scar Global Assessment (SGA) scale.Results: Systematic review: Three articles were included and reported improvements in acne scar severity. Adverse effects included erythema, edema, pain, vesicle formation, erosion, petechiae, desquamation, post‐inflammatory hyperpigmentation (PIH), and acne flare. Quality scores ranged from 14 to 15 (maximum of 21). Case series: Twenty‐six patients were included. Mean SGA Score was 3.0 at baseline and 1.3 at follow‐up. All patients had an improved SGA score. Adverse effects included erythema, pain, edema, skin crusting, PIH, and acne flare. All patients resumed normal activities within 7 days of treatment.Conclusion: Combination RF microneedling and fractional CO2 laser appears a safe and effective treatment for patients with acne scarring. A single treatment can result in noticeable improvements in acne scar severity with a short recovery time.


  • Open Access

    35 Comparative Performance of Prediction Model, Non-Expert and Tele-Diagnosis of Common External and Middle Ear Disease Using A Patient Cohort from Cambodia That Included One Hundred and Thirty-Eight Ears

    by J Schuster-Bruce, P Shetty, J O'DOnovan, R Mandavia, T Sokdavy, M Bhutta

    Globally 6% of the population suffers from disabling hearing loss and the majority resides in low- and middle-income countries, but diagnosis and treatment are hampered by poor availability of expert diagnosis. We compared the utility of tele-diagnosis, non-expert diagnosis, and prediction model diagnosis as a screening tool for common external and middle ear disorders. We recruited consecutive adult and paediatric patients presenting with ear or hearing symptoms to ENT outpatients at Children’s Surgical Centre, Cambodia. Each participant underwent sequential symptomatic and otoscopic assessment by a non-specialist and an ENT specialist. The non-specialist captured data using a novel automated symptom questionnaire loaded onto a smartphone otoscope. An ENT specialist in the UK subsequently reviewed these data. 138 ears were recruited. The prediction model performed poorly, but absence of otorrhoea was found to reliably exclude a diagnosis of chronic suppurative otitis media (negative predictive value=0.99). Both on-site non-expert and expert tele-diagnosis had high diagnostic specificity (90-99% and 86-99%), but low sensitivity (disorders of the middle/external ear, which shows suboptimal but comparable performance using an automated questionnaire, on site non-expert diagnosis, or remote expert diagnosis

  • Comparative performance of prediction model, non‐expert and telediagnosis of common external and middle ear disease using a patient cohort from Cambodia that included one hundred and thirty‐eight ears

    by James Schuster‐Bruce, Prajwal Shetty, James O’dOnovan, Rishi Mandavia, Touch Sokdavy, Mahmood F Bhutta

    Click on the article title to read more.


  • Open Access

    Prognostic factors for outcomes of idiopathic sudden sensorineural hearing loss: protocol for the SeaSHeL national prospective cohort study

    by Rishi Mandavia, Gerjon Hannink, Muhammad Nayeem Ahmed, Yaami Premakumar, Timothy Shun Man Chu, Helen Blackshaw, Tanjinah Ferdous, Nishchay Mehta, Joseph Manjaly, Maha Khan, et al.

    Introduction The mainstay of treatment for idiopathic sudden sensorineural hearing loss (SSNHL) includes oral steroids, intratympanic steroid injections or a combination of both. The National Institute for Health and Care Excellence, in their recent hearing loss guidelines, highlighted the paucity of evidence assessing the comparative effectiveness of these treatments; and the National Institute for Health Research (NIHR) Health Technology Assessment Programme has since released a commissioned call for a trial to identify the most effective route of administration of steroids as a first-line treatment for idiopathic SSNHL. For such trials to be run effectively, reliable information is needed on patients with SSNHL: where they present, numbers, demographics, treatment pathways, as well as outcomes. This study will collect these data in a nationwide cohort study of patients presenting with SSNHL across 97 National Health Service (NHS) trusts. The study will be delivered through ear, nose and throat (ENT) trainee networks, the NIHR Clinical Research Network (CRN) Audiology Champions and the NIHR CRN. Importantly, this study will also provide a dataset to develop a prognostic model to predict recovery for patients with idiopathic SSNHL. The study objectives are to: (1) map the patient pathway and identify the characteristics of adult patients presenting to NHS ENT and hearing services with SSNHL, (2) develop a prognostic model to predict recovery for patients with idiopathic SSNHL and (3) establish the impact of idiopathic SSNHL on patients’ quality of life (QoL). Methods and analysis Study design: national multicentre prospective cohort study across 97 NHS trusts. Inclusion criteria: adult patients presenting to NHS ENT and hearing services with SSNHL. Outcomes: change in auditory function; change in QoL score. Analysis: multivariable prognostic model, using prespecified candidate predictors. Mean change in QoL scores will be calculated from initial presentation to follow-up. Ethics and dissemination Health Research Authority and NHS Research Ethics Committee approved the study. Publication will be on behalf of study sites and collaborators. Trial registration number ClinicalTrials.gov Registry (NCT04108598).